Fig. 7From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong KongSurvival probability after the initiation of DAA therapy, stratified by the presence or absence of HCC before DAA therapy. CRR, complete radiologic responseBack to article page